Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally.
Halozyme Therapeutics stock last closed at $33.20, up 0.18% from the previous day, and has decreased 28.76% in one year. It has underperformed other stocks in the Biotechnology industry by 0.3 percentage points. Halozyme Therapeutics stock is currently +11.22% from its 52-week low of $29.85, and -44.16% from its 52-week high of $59.46.
There are currently 131.68M HALO shares outstanding. The market cap of HALO is $4.37B. In the last 24 hours, 671,780 HALO shares were traded.
You need a brokerage account to access the NASDAQ market and buy HALO stock.
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro now.Open eToro Account
Now that you've picked the best brokerage, the next step is to fill out some personal information so you are able to buy HALO today.
Now that you've filled out your info on app for stock, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of transferring money into your brokerage account.
After you have chosen the best place to buy Halozyme Therapeutics stock, it's crucial to evaluate their stock before you buy, so you actually comprehend the risk and opportunity.
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on HALO's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge HALO's intrinsic value.
Using relative valuations methods:
You can do additional valuation analysis on HALO's stock here.
Out of 8 Equities analysts who monitor HALO, the consensus analyst rating on Halozyme Therapeutics is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
Jason Butler, a bottom 17% analyst from JMP Securities reiterates HALO with a buy rating and maintains their HALO price target from $66.00 to $66.00, on May 10, 2023.
Vikram Purohit, a bottom 12% analyst from Morgan Stanley maintains HALO with a strong buy rating and lowers their HALO price target from $64.00 to $60.00, on May 10, 2023.
Joseph Catanzaro, a bottom 9% analyst from Piper Sandler upgrades HALO to a strong buy rating and announces their HALO price target of $46.00, on May 10, 2023.
Caroline Palomeque, a top 31% analyst from Berenberg reinstates HALO with a strong buy rating and announces their HALO price target of $58.00, on Mar 27, 2023.
Mohit Bansal, a top 13% analyst from Wells Fargo maintains HALO with a strong buy rating and lowers their HALO price target from $55.00 to $48.00, on Mar 17, 2023.
You can dig deeper into what analysts are projecting on the Halozyme Therapeutics stock forecast page.
Last year, HALO earnings were $181.64M. Over the past 5 year, HALO's earnings have grown by 21.13% per year. This was faster than the Biotechnology industry average of 18.73%.
Last year, HALO revenue was $704.98M. Over the past 5 year, HALO's revenue has increased by 17.27% per year. This was slower than the Biotechnology industry average of 89.01%.
Find out more about HALO's earnings and revenue performance here.
In the past year, insiders at HALO have sold more shares than they have bought.
Michael J. Labarre, SVP CHIEF TECHNICAL OFFICER of HALO, was the latest HALO insider to sell. They sold $360,000.00 worth of HALO shares on Apr 18, 2023.
Learn more about who owns HALO stock here.
No, Halozyme Therapeutics doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two primary types of orders:
Hit the Open button and eToro will place the order.
If you want additional help with buying stocks on eToro, watch the helpful video below:
Now that you own some HALO stock, you'll want to keep up with your new shares.
Put HALO on a watchlist to get notified of the latest news about your HALO stock.
To reiterate, here are the 6 steps to buy Halozyme Therapeutics stock:
If you are looking for a brokerage account, eToro is our recommended option.Get Started with eToro Today
If you want to monitor your new investment in Halozyme Therapeutics, get started below.
How much does it cost to buy one Halozyme Therapeutics share?
Is now a good time to buy Halozyme Therapeutics stock?
What is the best way to buy Halozyme Therapeutics stock?